卢立康唑、拉康唑和依氟康唑与五种抗真菌药物对黑化真菌及其亲缘种的活性比较。
Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.
机构信息
Department of Medical Parasitology and Mycology, School of Public Health, National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medical Mycology and Parasitology, Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
出版信息
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00635-17. Print 2017 Nov.
Abstract
The activities of novel azoles compared to those of five antifungal drugs against clinical ( = 28) and environmental ( = 102) isolates of black mold and melanized yeast were determined. Luliconazole and lanoconazole had the lowest geometric mean MICs, followed by efinaconazole, against tested isolates compared to the other drugs. Therefore, it appears that these new imidazole and triazole drugs are promising candidates for the treatment of infections due to melanized fungi and their relatives.
摘要
测定了新型唑类药物与五种抗真菌药物对临床（=28）和环境（=102）黑曲霉和黑化酵母分离株的活性。与其他药物相比，卢立康唑和拉诺康唑对测试分离株的几何平均 MIC 最低，其次是依非康唑。因此，这些新型咪唑和三唑类药物似乎是治疗由黑化真菌及其亲缘种引起的感染的有希望的候选药物。
相似文献
1
Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.卢立康唑、拉康唑和依氟康唑与五种抗真菌药物对黑化真菌及其亲缘种的活性比较。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00635-17. Print 2017 Nov.
2
Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates.新型三唑类药物依氟康唑和五种对照药物对皮肤癣菌分离株的抗真菌活性。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02423-17. Print 2018 May.
3
Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species.卢立康唑、拉康唑和 8 种对照剂对分子鉴定的镰刀菌属种的强效活性。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.00009-18. Print 2018 May.
4
[In vitro Antifungal Activity of Luliconazole against Trichophyton spp].卢立康唑对毛癣菌属的体外抗真菌活性
Med Mycol J. 2016;57(1):J1-6. doi: 10.3314/mmj.57.J1.
5
In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.新型唑类药物卢立康唑和拉诺康唑与其他十种抗真菌药物对临床皮肤癣菌分离株的体外活性比较
Med Mycol. 2016 Oct 1;54(7):757-63. doi: 10.1093/mmy/myw016. Epub 2016 Apr 26.
6
Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains.新型咪唑类药物兰诺康唑和卢立康唑对一系列唑类耐药和敏感烟曲霉菌株的强效活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6916-6919. doi: 10.1128/AAC.01193-16. Print 2016 Nov.
7
In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.卢立康唑对皮肤真菌病患者临床分离株的体外抗真菌活性。
J Infect Chemother. 2006 Jun;12(3):163-5. doi: 10.1007/s10156-006-0440-4.
8
In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent.新型咪唑类抗真菌药卢立康唑（NND - 502）的体外抗真菌活性
J Infect Chemother. 2004 Aug;10(4):216-9. doi: 10.1007/s10156-004-0327-1.
9
In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis.体外研究 15 种抗真菌药物对大量临床分离的犬小孢子菌的活性。
Mycoses. 2019 Nov;62(11):1069-1078. doi: 10.1111/myc.12986. Epub 2019 Oct 1.
10
In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.伊朗镰刀菌分离株的体外抗真菌药敏谱：强调与其他药物相比，艾氟康唑具有强大的抑制作用。
Mycoses. 2023 Mar;66(3):258-275. doi: 10.1111/myc.13550. Epub 2022 Dec 19.
引用本文的文献
1
Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis.载卢立康唑的纳米结构脂质载体凝胶在皮肤癣菌病动物模型中的抗真菌疗效
J Fungi (Basel). 2025 Apr 19;11(4):324. doi: 10.3390/jof11040324.
2
In Silico Guided Nanoformulation Strategy for Circumvention of Biofilm for Effective Therapy of Candidal Vulvovaginitis.用于规避生物膜以有效治疗念珠菌性外阴阴道炎的计算机辅助纳米制剂策略
ACS Omega. 2023 Feb 10;8(7):6918-6930. doi: 10.1021/acsomega.2c07718. eCollection 2023 Feb 21.
3
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.比较新型三唑类药物与经典抗真菌药物对从伊朗大学医院分离的皮肤癣菌属的体外活性：一项多中心研究。
Ann Clin Microbiol Antimicrob. 2023 Feb 20;22(1):15. doi: 10.1186/s12941-023-00564-4.
4
Isolation and molecular characterization of clinical and environmental dematiaceous fungi and relatives from Iran.伊朗临床和环境中暗色丝孢真菌及其亲缘种的分离与分子特征分析
Curr Med Mycol. 2021 Sep;7(3):1-8. doi: 10.18502/cmm.7.3.7798.
5
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran.从伊朗单一中心经验看，从外阴阴道念珠菌病分离的杜伦毕赤酵母和南非假丝酵母的分子鉴定和抗真菌药敏谱。
Mycoses. 2021 Jul;64(7):771-779. doi: 10.1111/myc.13280. Epub 2021 May 3.
6
Prediction of itraconazole minimum inhibitory concentration for Fonsecaea pedrosoi using Fourier Transform Infrared Spectroscopy (FTIR) and chemometrics.利用傅里叶变换红外光谱（FTIR）和化学计量学预测佩德罗索拟青霉的伊曲康唑最小抑菌浓度。
PLoS One. 2020 Dec 2;15(12):e0243231. doi: 10.1371/journal.pone.0243231. eCollection 2020.
7
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.红酵母属的分子鉴定、生物膜形成和抗真菌药敏性
Mol Biol Rep. 2020 Nov;47(11):8903-8909. doi: 10.1007/s11033-020-05942-1. Epub 2020 Nov 1.
8
The high efficacy of luliconazole against environmental and otomycosis strains.卢立康唑对环境菌株和耳霉菌株的高效性。
Iran J Microbiol. 2020 Apr;12(2):170-176.
9
Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates.新型三唑类药物艾氟康唑及其 9 种对照药物对 354 株分子鉴定的曲霉菌分离株的抗真菌活性。
Mycopathologia. 2020 Apr;185(2):357-365. doi: 10.1007/s11046-020-00434-z. Epub 2020 Feb 28.
10
Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates.新型三唑类药物依氟康唑和五种对照药物对皮肤癣菌分离株的抗真菌活性。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02423-17. Print 2018 May.
本文引用的文献
1
Molecular and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Characterization of Clinically Significant Melanized Fungi in India.基于分子和基质辅助激光解吸电离飞行时间质谱的印度临床重要黑化真菌特征分析
J Clin Microbiol. 2017 Apr;55(4):1090-1103. doi: 10.1128/JCM.02413-16. Epub 2017 Jan 18.
2
Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains.新型咪唑类药物兰诺康唑和卢立康唑对一系列唑类耐药和敏感烟曲霉菌株的强效活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6916-6919. doi: 10.1128/AAC.01193-16. Print 2016 Nov.
3
In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.新型唑类药物卢立康唑和拉诺康唑与其他十种抗真菌药物对临床皮肤癣菌分离株的体外活性比较
Med Mycol. 2016 Oct 1;54(7):757-63. doi: 10.1093/mmy/myw016. Epub 2016 Apr 26.
4
Dematiaceous Molds.暗色真菌
Infect Dis Clin North Am. 2016 Mar;30(1):165-78. doi: 10.1016/j.idc.2015.10.007.
5
Black Molds and Melanized Yeasts Pathogenic to Humans.对人类致病的黑色霉菌和黑化酵母。
Cold Spring Harb Perspect Med. 2014 Nov 10;5(8):a019570. doi: 10.1101/cshperspect.a019570.
6
Luliconazole for the treatment of fungal infections: an evidence-based review.卢立康唑治疗真菌感染：一项基于证据的综述。
Core Evid. 2014 Sep 24;9:113-24. doi: 10.2147/CE.S49629. eCollection 2014.
7
Efinaconazole (Jublia) for the treatment of onychomycosis.依氟鸟氨酸（Jublia）治疗甲真菌病。
Expert Rev Anti Infect Ther. 2014 Jul;12(7):743-52. doi: 10.1586/14787210.2014.919852. Epub 2014 May 22.
8
Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health.由于农业领域使用唑类药物，导致对唑类耐药的烟曲霉菌株出现，这对人类健康构成了日益严重的威胁。
PLoS Pathog. 2013 Oct;9(10):e1003633. doi: 10.1371/journal.ppat.1003633. Epub 2013 Oct 24.
9
Mechanism of action of efinaconazole, a novel triazole antifungal agent.新型三唑类抗真菌药物依氟康唑的作用机制。
Antimicrob Agents Chemother. 2013 May;57(5):2405-9. doi: 10.1128/AAC.02063-12. Epub 2013 Mar 4.
10
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.荚膜组织胞浆菌（Cladophialophora carrionii），一种人类着色芽生菌病的病原体，其体外抗真菌药敏性研究。
Antimicrob Agents Chemother. 2013 Apr;57(4):1974-7. doi: 10.1128/AAC.02114-12. Epub 2013 Feb 4.
Zotero 插件